Koers Kaneh Bosm Biotechnology Inc Canadian Securities Exchange
Aandelen
CA4841902022
Drugshandelaren
Omzet 2018 | - | Omzet 2019 | - | Marktkapitalisatie | 13,23 mln. 18,17 mln. 12,36 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2018 | - 0 0 | Nettowinst (verlies) 2019 | -60 mln. -82,41 mln. -56,06 mln. | EV/omzet 2018 * | - |
Nettoliquiditeiten 2018 * | - 0 0 | Nettoliquiditeiten 2019 * | - 0 0 | EV/omzet 2019 * | - |
K/w-verhouding 2018 * |
-
| K/w-verhouding 2019 * |
-
| Werknemers | - |
Dividendrendement 2018 * |
-
| Dividendrendement 2019 * |
-
| Vrij verhandelbaar | 0% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Shpilt
CEO | Chief Executive Officer | - | 15-04-19 |
Eugene Beukman
BRD | Director/Board Member | 64 | 27-04-18 |
Corporate Officer/Principal | - | 25-04-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Eugene Beukman
BRD | Director/Board Member | 64 | 27-04-18 |
Matthew Fish
BRD | Director/Board Member | - | 29-05-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,90% | 2,67 mld. | |
-25,17% | 1,11 mld. | |
+44,82% | 492 mln. | |
-15,91% | 392 mln. | |
-3,90% | 92,03 mln. | |
-29,80% | 73,25 mln. | |
+38,20% | 55,55 mln. | |
+16,25% | 53,5 mln. |